MedTrace Logo

Screening of Hereditary Upper Gastrointestinal Cancer in China

NCT03130621 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-06-04

No results posted yet for this study

Summary

Through exploring the specific genetic mutations in the upper gastrointestinal tract tumors with a family history and specific clinical pathological types，we establish a complete family and follow-up system，in order to improve the screening criteria of Chinese hereditary upper gastrointestinal tumors and carry on primary prevention of disease.

Conditions

  • Improve the Screening Criteria of Chinese Hereditary Upper Gastrointestinal Tumors

Interventions

DIAGNOSTIC_TEST

Gene detection

Next-generation sequencing

Sponsors & Collaborators

  • Peking University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03130621 on ClinicalTrials.gov